TDEs activate the NF-κB pathway to maintain the survival of TANs in colorectal and gastric cancer and recruit neutrophils via promoting the secretion of IL-8 16, 17, a canonical downstream chemokine of the NF-κB pathway 47. The gene discussed is NFKB1; the disease is gastric cancer.